Triglycerides and Residual Atherosclerotic Risk

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

(2020) Jan Borén et al.   EUROPEAN HEART JOURNAL

Association of four lipid components with mortality, myocardial infarction, and stroke in statin-naïve young adults: A nationwide cohort study

(2020) Heesun Lee et al.   European Journal of Preventive Cardiology

Short-Term Progression of Multiterritorial Subclinical Atherosclerosis

(2020) Beatriz López-Melgar et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Inflammation and features of the vulnerable plaque: from mechanisms and imaging to outcomes

(2020) Thomas F Lüscher   EUROPEAN HEART JOURNAL

Association Between Body Size Phenotypes and Subclinical Atherosclerosis

(2020) Xavier Rossello et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk

(2020) Stephen J. Nicholls et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease

(2019) Brian A. Ference et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Vascular Inflammation in Subclinical Atherosclerosis Detected by Hybrid PET/MRI

(2019) Leticia Fernández-Friera et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP)

(2019) Xavier Rossello et al.   European Journal of Preventive Cardiology

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Subclinical atherosclerosis, cardiovascular health, and disease risk: is there a case for the Cardiovascular Health Index in the primary prevention population?

(2018) Sarah S. Singh et al.   BMC PUBLIC HEALTH

Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators

(2018) Charles N. Serhan et al.   JOURNAL OF CLINICAL INVESTIGATION

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

(2018) Deepak L. Bhatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors

(2017) Leticia Fernández-Friera et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

(2017) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

From Lipids to Inflammation

(2016) Michael D. Shapiro et al.   CIRCULATION RESEARCH

Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease

(2016) Robert Klempfner et al.  

Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease

(2016) Robert Klempfner et al.   Circulation-Cardiovascular Quality and Outcomes

Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study

(2015) L. Fernandez-Friera et al.   CIRCULATION

Triglycerides and cardiovascular disease

(2014) Børge G Nordestgaard et al.   LANCET

Pro-resolving lipid mediators are leads for resolution physiology

(2014) Charles N. Serhan   NATURE

The Progression and Early detection of Subclinical Atherosclerosis (PESA) study: Rationale and design

(2013) Antonio Fernández-Ortiz et al.   AMERICAN HEART JOURNAL

Nonoptimal Lipids Commonly Present in Young Adults and Coronary Calcium Later in Life: The CARDIA (Coronary Artery Risk Development in Young Adults) Study

(2013) Mark J. Pletcher   ANNALS OF INTERNAL MEDICINE

Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation

(2013) Anette Varbo et al.   CIRCULATION

Progression of Coronary Calcium and Incident Coronary Heart Disease Events

(2013) Matthew J. Budoff et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

(2011) M. John Chapman et al.   EUROPEAN HEART JOURNAL

Risk Factor Differences for Aortic Versus Coronary Calcified Atherosclerosis

(2010) Michael H. Criqui et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Comparative effects of DHA and EPA on cell function

(2009) Renata Gorjão et al.   PHARMACOLOGY & THERAPEUTICS

Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial

(2008) Michael Miller et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE